The continuing stock market rally, at a time when the pandemic-hit economy is struggling to regain strength, has set off an IPO
IPO News: Should you invest in Sight Sciences’ initial public offering?
Categories
Health Care
Avid Bioservices, Inc. (CDMO) Q4 2021 Earnings Call Transcript
Avid Bioservices, Inc. (NASDAQ: CDMO) Q4 2021 earnings call dated Jun. 29, 2021 Corporate Participants: Tim Brons -- Executive Vice President, Vida Strategic Partners,
Aerovate Therapeutics IPO: What awaits the biotech firm after market debut?
The IPO market has continued the bull run so far this year, unfazed by the virus-related uncertainties, with the technology and pharma
Thermo Fisher (TMO) stock can add value to your portfolio. Here’s why
For Thermo Fisher Scientific Inc. (NYSE: TMO), a leading player in the medical diagnostics and life sciences market, 2020 was a busy
Rite Aid Corporation (RAD) Q1 2022 Earnings Call Transcript
Rite Aid Corporation (NYSE: RAD) Q1 2022 earnings call dated Jun. 24, 2021 Corporate Participants: Trent Kruse -- Senior Vice President, Investor Relations and
Context Therapeutics: Another clinical-stage oncology research firm to go public soon
The US primary markets seem to be having a record-breaking start to the year, with over $171 billion raised in the first
Biogen (BIIB) Stock: Does FDA nod for Aduhelm offer a buying opportunity?
The pharmaceutical industry has been witnessing hectic activity for some time, with most drug makers either channelizing their resources for vaccine development
Patterson Companies, Inc. (PDCO) Q4 2021 Earnings Call Transcript
Patterson Companies, Inc. (NASDAQ: PDCO) Q4 2021 earnings call dated Jun. 23, 2021 Corporate Participants: John M. Wright -- Vice President, Investor Relations Mark
IPO News: Monte Rosa Therapeutics will go public this week, here are a few things to know
Biotechnology company Monte Rosa Therapeutics is slated to go public this week. In a pandemic-ridden world, this industry is expanding at a
IPO News: What to look for when Elevation Oncology makes its Wall Street debut
The healthcare sector is going through a phase of consolidation, creating fresh opportunities for emerging companies in a market that is slowly
Trxade Health Inc. (NASDAQ: MEDS) Q2 2021 Research Summary
Trxade Health Inc. (NASDAQ: MEDS), a health services IT company, plays a key role in ensuring the availability of healthcare services at
BeyondSpring, Inc.(BYSI) Q1 2021 Earnings Call Transcript
BeyondSpring, Inc. (NASDAQ: BYSI) Q1 2021 earnings call dated Jun. 16, 2021 Corporate Participants: Ashley R. Robinson -- Media & Investor Relations of LifeSci
Is Merck (MRK) stock still a buy after losing the vaccine race?
After bringing the global economy to a grinding halt, the coronavirus pandemic is subsiding in most regions, thanks to the mass production
LLY Stock: Is Eli Lilly a good bet in COVID-challenged healthcare market?
For pharmaceutical companies, 2020 was a busy year when the healthcare sector went into overdrive to deal with the challenges posed by
HealthEquity Inc (HQY) Q1 2022 Earnings Call Transcript
HealthEquity Inc (NASDAQ:HQY) Q1 2022 earnings call dated Jun. 07, 2021. Corporate Participants: Richard Putnam -- Investor Relations Jon Kessler -- President and Chief Executive Officer
Cupid Limited (CUPID) Q4 2021 Earnings Call Transcript
Cupid Limited (NSE:CUPID) Q4 2021 earnings call dated Jun. 04, 2021 Corporate Participants: Binay Sarda -- Christensen Investor Relations Om Prakash Garg -- Chairman and Managing
Medtronic PLC (MDT) Q4 2021 Earnings Call Transcript
Medtronic PLC (NYSE: MDT) Q4 2021 earnings call dated May 27, 2021 Corporate Participants: Ryan Weispfenning -- Vice President, Investor Relations Karen L. Parkhill -- Executive
Agilent Technologies Inc (A) Q2 2021 Earnings Call Transcript
Agilent Technologies Inc (NYSE:A) Q2 2021 earnings call dated May. 25, 2021. Corporate Participants: Ruben DiRado -- Director, Investor Relations Mike McMullen -- President and Chief
Moderna, Inc. (MRNA) Q1 2021 Earnings Call
Moderna, Inc. (NASDAQ: MRNA) Q1 2021 earnings call dated May. 06, 2021 Corporate Participants: Lavina Talukdar — Senior Vice President and Head of Investor Relations
Bio-Path Holdings, Inc. (BPTH) Q1 2021 Earnings Call Transcript
Bio-Path Holdings, Inc. (NASDAQ: BPTH) Q1 2021 earnings call dated May. 14, 2021 Corporate Participants: Will O'Connor -- Investor Relations, Stern Investor Relations, Inc.
ImmunoGen’s post-earnings dip could be a good buying opportunity
Earlier this week, biotech company ImmunoGen (NASDAQ: IMGN) reported mixed financial results for the first quarter of 2021, pushing the stock into